Detalhe da pesquisa
1.
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Blood Adv
; 8(2): 429-440, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871309
2.
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
Blood Adv
; 7(17): 5000-5013, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142255
3.
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines.
Leukemia
; 35(12): 3578-3580, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741117